Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Outlook Therapeutics Inc. (OTLK)

  • Technical Exchange News
  • Feb. 25, 2026, 19:05 UTC
  • 38
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

CASI Pharmaceuticals Inc. (CASI)

  • Technical Exchange News
  • Feb. 25, 2026, 19:04 UTC
  • 42
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Rallybio Corporation (RLYB)

  • Technical Exchange News
  • Feb. 25, 2026, 02:42 UTC
  • 55
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Mereo BioPharma (MREO)

  • Technical Exchange News
  • Feb. 25, 2026, 02:41 UTC
  • 59
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Rallybio Corporation (RLYB)

  • Technical Exchange News
  • Feb. 24, 2026, 19:31 UTC
  • 60
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Mereo BioPharma (MREO)

  • Technical Exchange News
  • Feb. 24, 2026, 19:31 UTC
  • 58
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

ENLIVEX (ENLV)

  • Technical Exchange News
  • Feb. 24, 2026, 08:09 UTC
  • 69
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Enlivex Therapeutics Ltd. - Ordinary Shares. New value: Enlivex Ltd. - Ordinary Shares.

Comment Full text

Envoy Medical Inc (COCHW)

  • Technical Exchange News
  • Feb. 24, 2026, 03:01 UTC
  • 56
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Adial Pharmaceuticals Inc (ADIL)

  • Technical Exchange News
  • Feb. 24, 2026, 03:01 UTC
  • 54
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

ENLIVEX (ENLV)

  • Technical Exchange News
  • Feb. 24, 2026, 00:50 UTC
  • 42
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Enlivex Therapeutics Ltd. - Ordinary Shares. New value: Enlivex Ltd. - Ordinary Shares.

Comment Full text
  • Previous
  • 320
  • 321
  • 322
  • 323
  • 324
  • Next

Search

News categories

  • Technical Exchange News(14191)
  • Event(6229)
  • SEC News(362588)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(223024)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin